These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 33451989)

  • 1. Serum calprotectin as new biomarker for disease severity in idiopathic pulmonary fibrosis: a cross-sectional study in two independent cohorts.
    Machahua C; Guler SA; Horn MP; Planas-Cerezales L; Montes-Worboys A; Geiser TK; Molina-Molina M; Funke-Chambour M
    BMJ Open Respir Res; 2021 Jan; 8(1):. PubMed ID: 33451989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peripheral blood proteomic profiling of idiopathic pulmonary fibrosis biomarkers in the multicentre IPF-PRO Registry.
    Todd JL; Neely ML; Overton R; Durham K; Gulati M; Huang H; Roman J; Newby LK; Flaherty KR; Vinisko R; Liu Y; Roy J; Schmid R; Strobel B; Hesslinger C; Leonard TB; Noth I; Belperio JA; Palmer SM;
    Respir Res; 2019 Oct; 20(1):227. PubMed ID: 31640794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated serum human epididymis protein 4 is associated with disease severity and worse survival in idiopathic pulmonary fibrosis: a cohort study.
    Tian M; Meng K; Gao Y; Zhang J; Xie M; Tian Y; Liu X; Ma M; Cai Y; Wu H; Ding J; Chen J; Cai H
    Ann Transl Med; 2022 Sep; 10(18):992. PubMed ID: 36267722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple breath washout: A new and promising lung function test for patients with idiopathic pulmonary fibrosis.
    Nyilas S; Schreder T; Singer F; Poellinger A; Geiser TK; Latzin P; Funke M
    Respirology; 2018 Aug; 23(8):764-770. PubMed ID: 29573509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of surfactant protein A, surfactant protein D, Clara cell protein 16, S100 protein, trefoil factor 3, and prostatic secretory protein 94 in idiopathic pulmonary fibrosis, sarcoidosis, and chronic pulmonary obstructive disease.
    Doubková M; Karpíšek M; Mazoch J; Skřičková J; Doubek M
    Sarcoidosis Vasc Diffuse Lung Dis; 2016 Oct; 33(3):224-234. PubMed ID: 27758987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Change in serum marker of oxidative stress in the progression of idiopathic pulmonary fibrosis.
    Matsuzawa Y; Kawashima T; Kuwabara R; Hayakawa S; Irie T; Yoshida T; Rikitake H; Wakabayashi T; Okada N; Kawashima K; Suzuki Y; Shirai K
    Pulm Pharmacol Ther; 2015 Jun; 32():1-6. PubMed ID: 25862941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matrix metalloproteinase-10: a novel biomarker for idiopathic pulmonary fibrosis.
    Sokai A; Handa T; Tanizawa K; Oga T; Uno K; Tsuruyama T; Kubo T; Ikezoe K; Nakatsuka Y; Tanimura K; Muro S; Hirai T; Nagai S; Chin K; Mishima M
    Respir Res; 2015 Sep; 16():120. PubMed ID: 26415518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of the prognostic value of MMP-7 in idiopathic pulmonary fibrosis.
    Tzouvelekis A; Herazo-Maya JD; Slade M; Chu JH; Deiuliis G; Ryu C; Li Q; Sakamoto K; Ibarra G; Pan H; Gulati M; Antin-Ozerkis D; Herzog EL; Kaminski N
    Respirology; 2017 Apr; 22(3):486-493. PubMed ID: 27761978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disease Severity and Quality of Life in Patients With Idiopathic Pulmonary Fibrosis: A Cross-Sectional Analysis of the IPF-PRO Registry.
    O'Brien EC; Hellkamp AS; Neely ML; Swaminathan A; Bender S; Snyder LD; Culver DA; Conoscenti CS; Todd JL; Palmer SM; Leonard TB;
    Chest; 2020 May; 157(5):1188-1198. PubMed ID: 31954102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disease progression in idiopathic pulmonary fibrosis with mild physiological impairment: analysis from the Australian IPF registry.
    Jo HE; Glaspole I; Moodley Y; Chapman S; Ellis S; Goh N; Hopkins P; Keir G; Mahar A; Cooper W; Reynolds P; Haydn Walters E; Zappala C; Grainge C; Allan H; Macansh S; Corte TJ
    BMC Pulm Med; 2018 Jan; 18(1):19. PubMed ID: 29370786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum carcinoembryonic antigen correlates with severity of idiopathic pulmonary fibrosis.
    Fahim A; Crooks MG; Wilmot R; Campbell AP; Morice AH; Hart SP
    Respirology; 2012 Nov; 17(8):1247-52. PubMed ID: 22816375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the Diagnostic Efficacies of Serological Markers KL-6, SP-A, SP-D, CCL2, and CXCL13 in Idiopathic Interstitial Pneumonia.
    Xue M; Guo Z; Cai C; Sun B; Wang H
    Respiration; 2019; 98(6):534-545. PubMed ID: 31665737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum metabolic profiling identified a distinct metabolic signature in patients with idiopathic pulmonary fibrosis - a potential biomarker role for LysoPC.
    Rindlisbacher B; Schmid C; Geiser T; Bovet C; Funke-Chambour M
    Respir Res; 2018 Jan; 19(1):7. PubMed ID: 29321022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential role of SIRT-1 and SIRT-3 as biomarkers for the diagnosis and prognosis of idiopathic pulmonary fibrosis.
    Perrotta F; D'Agnano V; Mariniello DF; Castaldo G; Vitale M; Cazzola M; Bianco A; Scialò F
    Respir Res; 2024 Apr; 25(1):189. PubMed ID: 38678247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum amyloid A in patients with idiopathic pulmonary fibrosis.
    Vietri L; Bennett D; Cameli P; Bergantini L; Cillis G; Sestini P; Bargagli E; Rottoli P
    Respir Investig; 2019 Sep; 57(5):430-434. PubMed ID: 31031123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased levels of serum Wisteria floribunda agglutinin-positive Mac-2 binding protein in idiopathic pulmonary fibrosis.
    Kono M; Nakamura Y; Oyama Y; Mori K; Hozumi H; Karayama M; Hashimoto D; Enomoto N; Fujisawa T; Inui N; Yamada M; Hamada E; Colby TV; Maekawa M; Suda T
    Respir Med; 2016 Jun; 115():46-52. PubMed ID: 27215503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Volatile Organic Compounds in Exhaled Breath of Idiopathic Pulmonary Fibrosis for Discrimination from Healthy Subjects.
    Yamada YI; Yamada G; Otsuka M; Nishikiori H; Ikeda K; Umeda Y; Ohnishi H; Kuronuma K; Chiba H; Baumbach JI; Takahashi H
    Lung; 2017 Apr; 195(2):247-254. PubMed ID: 28247041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery and validation of extracellular/circulating microRNAs during idiopathic pulmonary fibrosis disease progression.
    Yang G; Yang L; Wang W; Wang J; Wang J; Xu Z
    Gene; 2015 May; 562(1):138-44. PubMed ID: 25725128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of MMP28 as a biomarker for the differential diagnosis of idiopathic pulmonary fibrosis.
    Maldonado M; Buendía-Roldán I; Vicens-Zygmunt V; Planas L; Molina-Molina M; Selman M; Pardo A
    PLoS One; 2018; 13(9):e0203779. PubMed ID: 30208119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Characteristics and clinical significance of pulmonary function test and KL-6 in ASSD-ILD and IPF].
    Sun D; Cheng Z; Jiang TC; Li PF; Jia LQ; Wang TT; Zheng CP; Li Y; Duo MJ
    Zhonghua Yi Xue Za Zhi; 2020 Mar; 100(10):748-752. PubMed ID: 32192286
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.